Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma

NCT01771107 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

41

Enrollment

NIH

Sponsor class

Conditions

AIDS-Related Hodgkin Lymphoma
Ann Arbor Stage II Hodgkin Lymphoma
Ann Arbor Stage IIA Hodgkin Lymphoma
Ann Arbor Stage IIB Hodgkin Lymphoma
Ann Arbor Stage III Hodgkin Lymphoma
Ann Arbor Stage IIIA Hodgkin Lymphoma
Ann Arbor Stage IIIB Hodgkin Lymphoma
Ann Arbor Stage IV Hodgkin Lymphoma
Ann Arbor Stage IVA Hodgkin Lymphoma
Ann Arbor Stage IVB Hodgkin Lymphoma
Classic Hodgkin Lymphoma
HIV Infection

Interventions

DRUG: Brentuximab Vedotin
DRUG: Dacarbazine
DRUG: Doxorubicin Hydrochloride
OTHER: Pharmacological Study
DRUG: Vinblastine

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]